TETRAPHASE PHARMACEUTICALS INC Payments for Restructuring
TETRAPHASE PHARMACEUTICALS INC reported Payments for Restructuring of $1.81 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2020-05-07
- TETRAPHASE PHARMACEUTICALS INC payments for restructuring for the quarter ending 2020-03-31 was $1.81M.
- TETRAPHASE PHARMACEUTICALS INC payments for restructuring for the quarter ending 2019-12-31 was $225.00K.
- TETRAPHASE PHARMACEUTICALS INC payments for restructuring for the quarter ending 2019-06-30 was $372.00K.
- TETRAPHASE PHARMACEUTICALS INC payments for restructuring for fiscal 2019 was $1.55M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2020-03-31 | $1.81M 10-Q · filed 2020-05-07 | $2.04M derived: sum of 2 quarters · filed 2020-05-07 | ||
| 2019-12-31 | $225.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $1.55M 10-K · filed 2020-03-12 | ||
| 2019-09-30 | $1.32M 10-Q · filed 2019-11-12 | |||
| 2019-06-30 | $372.00K 10-Q · filed 2019-08-08 |